SIRONAX: NOVARTIS EXERCISED EXCLUSIVE OPTION TO ACQUIRE FULL GLOBAL RIGHTS TO CO'S PROPRIETARY BRAIN DELIVERY PLATFORM FOLLOWING DEAL FROM JULY 2025

Reuters · 2d ago

Please log in to view news